Wedbush Securities’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.27M | Sell |
16,203
-731
| -4% | -$57.2K | 0.04% | 345 |
|
2025
Q1 | $1.23M | Sell |
16,934
-874
| -5% | -$63.3K | 0.05% | 332 |
|
2024
Q4 | $1.32M | Sell |
17,808
-449
| -2% | -$33.2K | 0.05% | 299 |
|
2024
Q3 | $1.21M | Sell |
18,257
-632
| -3% | -$41.7K | 0.04% | 320 |
|
2024
Q2 | $1.75M | Buy |
18,889
+285
| +2% | +$26.3K | 0.06% | 227 |
|
2024
Q1 | $1.78M | Sell |
18,604
-615
| -3% | -$58.8K | 0.07% | 234 |
|
2023
Q4 | $1.47M | Sell |
19,219
-370
| -2% | -$28.2K | 0.06% | 230 |
|
2023
Q3 | $1.36M | Sell |
19,589
-1,023
| -5% | -$70.9K | 0.07% | 227 |
|
2023
Q2 | $1.94M | Sell |
20,612
-3,235
| -14% | -$305K | 0.09% | 160 |
|
2023
Q1 | $1.97M | Sell |
23,847
-2,930
| -11% | -$242K | 0.1% | 159 |
|
2022
Q4 | $2M | Sell |
26,777
-2,511
| -9% | -$187K | 0.11% | 144 |
|
2022
Q3 | $2.42M | Buy |
29,288
+829
| +3% | +$68.5K | 0.14% | 118 |
|
2022
Q2 | $2.71M | Sell |
28,459
-1,174
| -4% | -$112K | 0.15% | 111 |
|
2022
Q1 | $3.49M | Buy |
29,633
+447
| +2% | +$52.6K | 0.16% | 102 |
|
2021
Q4 | $3.78M | Buy |
29,186
+6,173
| +27% | +$800K | 0.16% | 97 |
|
2021
Q3 | $2.61M | Buy |
23,013
+518
| +2% | +$58.6K | 0.12% | 130 |
|
2021
Q2 | $2.33M | Buy |
22,495
+5,124
| +29% | +$531K | 0.11% | 156 |
|
2021
Q1 | $1.45M | Buy |
17,371
+2,056
| +13% | +$172K | 0.08% | 232 |
|
2020
Q4 | $1.4M | Sell |
15,315
-2,168
| -12% | -$198K | 0.12% | 181 |
|
2020
Q3 | $1.4M | Buy |
17,483
+97
| +0.6% | +$7.74K | 0.13% | 161 |
|
2020
Q2 | $1.2M | Buy |
17,386
+925
| +6% | +$64K | 0.11% | 184 |
|
2020
Q1 | $1.04M | Buy |
16,461
+1,452
| +10% | +$91.3K | 0.12% | 169 |
|
2019
Q4 | $1.17M | Buy |
15,009
+939
| +7% | +$73K | 0.1% | 211 |
|
2019
Q3 | $1.03M | Sell |
14,070
-75
| -0.5% | -$5.5K | 0.1% | 230 |
|
2019
Q2 | $871K | Sell |
14,145
-480
| -3% | -$29.6K | 0.09% | 260 |
|
2019
Q1 | $933K | Buy |
14,625
+1,215
| +9% | +$77.5K | 0.1% | 234 |
|
2018
Q4 | $685K | Buy |
13,410
+4,380
| +49% | +$224K | 0.09% | 265 |
|
2018
Q3 | $524K | Buy |
9,030
+72
| +0.8% | +$4.18K | 0.06% | 377 |
|
2018
Q2 | $435K | Sell |
8,958
-3,972
| -31% | -$193K | 0.05% | 420 |
|
2018
Q1 | $601K | Sell |
12,930
-10,341
| -44% | -$481K | 0.08% | 306 |
|
2017
Q4 | $874K | Buy |
23,271
+810
| +4% | +$30.4K | 0.11% | 230 |
|
2017
Q3 | $818K | Sell |
22,461
-2,238
| -9% | -$81.5K | 0.11% | 221 |
|
2017
Q2 | $973K | Buy |
24,699
+1,200
| +5% | +$47.3K | 0.13% | 197 |
|
2017
Q1 | $737K | Sell |
23,499
-7,062
| -23% | -$221K | 0.1% | 244 |
|
2016
Q4 | $955K | Buy |
30,561
+25,020
| +452% | +$782K | 0.14% | 170 |
|
2016
Q3 | $223K | Buy |
+5,541
| New | +$223K | 0.03% | 626 |
|